Skip to content

To evaluate and compare the efficacy and safety of neutral oral cream to heal mucosal wound against placebo on healthy subjects over a 14 day period of home use.

To evaluate and compare the efficacy and safety of neutral oral cream to heal mucosal wound against placebo on healthy subjects over a 14 day period of home use.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/001242
Enrollment
90
Registered
2010-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Oral wound healing (clinical and size of wound)- Neutral oral Cream with ZnCl2 (active) with antioxidants: Topical Application, twice daily for 14 days. Control Intervention1: Neutral O

Sponsors

Smilecare Clinic Pvt. Ltd. 13, Geetanjali, 234, S. V. Road, Bandra (W), Mumbai- 400 050
Lead Sponsor
The Procter &amp
Collaborator
Gamble Company General Offices, One Procter &amp
Collaborator
Gamble Plaza, Cincinnati, Ohio, 45202, USA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ability to understand and sign a consent form prior to the recruitment on the study. 2. Male subjects 18 -30 years old 3. Minimum 24, non restored natural teeth. 5. Good general and oral health 6. Ability and willingness of subjects to follow the study procedures attend all scheduled visits and successfully complete the study

Exclusion criteria

Exclusion criteria: 1. Compromise Medical Conditions (History of any bleeding disorder/ diabetes/ hepatitis/ hypertension/ anemia) 2. Systemic ailments or on- going medicaments 3. Mouth wash users 4. Periodontitis/ gum recession/ ulcers/ any other oral soft tissue lesions 5. Active caries 6. Smokers and compulsive tobacco chewers 7. Orthodontic appliances/ dentures 8. Any known allergy (any dental or oral hygiene products) 9. Use of antibiotics/ anti-inflammatory 15 days prior to the enrollment of the subject to the study 10. Participating in any other trials

Design outcomes

Primary

MeasureTime frame
Initial wound area compared to wound area after 14 days home use.Timepoint: 14 Days

Secondary

MeasureTime frame
Initial Scores of clinical wound healing parameter (redness, swelling,sloughing, start of keratinization) compared to scores after 14 days home useTimepoint: 14 days

Countries

India

Contacts

Public ContactRagi Menon
ragi@smilecareindia.com91 22 26431670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026